Replies to post #19055 on Momenta Pharmaceuticals, Inc. (MNTA)

[imnot6]

It's good news in that it's news that isn't bad.

[Regulardoc]

Momenta's Humira will be a non-starter.

I am hearing that AbbVie dropped the price of Humira in Europe by 80% to combat the biosimilars yet still is able to have a 75% profit margin on the drug.

The US users are taking it on the chin.